Yahoo Finance Results
- Benzinga via Yahoo FinanceJul 05 17:30 PM
Boeing Co (NYSE: BA)’s new 80-percent stake in Embraer SA (ADR) (NYSE: ERJ)’s commercial jet business extends a theme that defined deals in the first half of 2018. The period saw more than $2.5 ...
Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050Business Insider3 days ago
Novartis' retreat follows a growing trend of big pharmaceutical companies — including AstraZeneca, Sanofi, and Allergan — that are exiting from this type of research because of a lack ...
- SearchSecurity.com5 hours ago
- Medscape4 days ago
- Fortune via Yahoo FinanceJul 03 19:44 PM
The image of the gray-haired family physician, stethoscope in ear, patiently listening to the heartbeat of a porcelain doll as his young patient looks on, is indelible in the public memory.
- Motley Fool via Yahoo FinanceJul 01 12:00 PM
In June 2016, AbbVie doled out $5.8 billion to acquire Stemcentrx for its cancer stem-cell therapy called Rova-T (rovalpituzumab tesirine) as a possible game-changing treatment for small-cell ...
- Motley Fool via Yahoo FinanceJul 14 0:24 AM
Read on to see why they picked Teva Pharmaceutical Industries (NYSE: TEVA), Apple (NASDAQ: AAPL), and Sanofi SA (NYSE: SNE). George Budwell (Sanofi): French drugmaker Sanofi ...
- InvestorPlace via Yahoo FinanceJul 10 19:00 PM
Rumors of potential acquirers have swirled for some time. BlackBerry of course almost went private back in 2013 at $9-per-share. Two years later, the company reportedly was in talks with Samsung about an acquisition.
Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage TrialBenzinga via Yahoo FinanceJul 12 12:37 PM
NASDAQ: DXCM) Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Illumina, Inc. NASDAQ: ILMN) Intuitive Surgical, Inc. NASDAQ: ISRG) Krystal Biotech Inc (NASDAQ: KRYS) Myriad Genetics, Inc.
- Reuters via Yahoo FinanceJul 09 19:48 PM
A. to set up a joint venture (approved July 6) -- U.S. private equity firms HPS Investment Partners and Madison Dearborn Partners to acquire joint control of British healthcare provider ...
- Benzinga via Yahoo FinanceJul 05 16:25 PM
Insys Therapeutics Inc (NASDAQ: INSY) has a July 28 FDA date and is set to receive the verdict on the company's sublingual spray formulation of buprenorphine to treat moderate-to-severe acute ...
News about Sanofi-Aventis. Commentary and archival information about Sanofi-Aventis from The New York Times.
Sanofi S.A. stock price, stock quotes and financial overviews from MarketWatch.
Every day, Sanofi’s 100,000 employees are committed to improve the lives of people around the world, with sustainable and responsible solutions and initiatives.
Stock analysis for Sanofi (SAN:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile.